Coeptis Therapeutics, Inc.COEPNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
95.49%
↑ 100% above average
Average (29q)
-51608.63%
Historical baseline
Range
High:95.49%
Low:-978378.00%
Volatility
-1895.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 95.49% |
| Q2 2025 | -15.60% |
| Q1 2025 | -1.53% |
| Q4 2024 | -64.68% |
| Q3 2024 | 39.75% |
| Q2 2024 | -1.13% |
| Q1 2024 | 20.08% |
| Q4 2023 | 40.86% |
| Q3 2023 | -98.29% |
| Q2 2023 | 59.76% |
| Q1 2023 | -170.40% |
| Q4 2022 | 47.90% |
| Q3 2022 | 42.38% |
| Q2 2022 | 48.89% |
| Q1 2022 | -1476.41% |
| Q4 2021 | 79.54% |
| Q3 2021 | -119.16% |
| Q2 2021 | -39.13% |
| Q1 2021 | -298.59% |
| Q4 2020 | -978378.00% |
| Q3 2020 | 88.89% |
| Q2 2020 | -22600.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q4 2005 | -1757.52% |
| Q3 2005 | 95.00% |
| Q2 2005 | -543896.88% |
| Q1 2005 | 0.00% |
| Q4 2004 | 0.00% |
| Q3 2004 | 0.00% |